Total Funding
84
41
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
368713
Terpenoid Therapeutics is a drug discovery and development company focused on drug candidates for cancer.
Raymond J. Hohl: Co-founder & President- Jeffrey D. Neighbors: Founder and Director of Drug Development
About the Company
Terpenoid Therapeutics, Inc. is a drug discovery and development company focused on cancer. They use the platform of terpene chemistry to develop candidate drug molecules. Their team is creating, testing, and developing novel drug candidates using cutting-edge technologies. They seek to generate a robust pipeline of terpene-derived therapeutic
agents.
Terpenoid projects are built upon a fifteen-year academic collaboration of the Terpenoid founders who have expertise in the biology and chemistry of terpene metabolism, pharmacology and oncology. The company is located in the University of Iowa Technology Innovation Center in Coralville, IA. The company maintains active collaborations with the academic labs of the founders.
